Historical salary details - Dr. Richard H. Scheller, PhD, Director, 23andMe Holding Co - Ordinary Shares - Class A
Dr. Richard H. Scheller, PhD is the Director of 23andMe Holding Co - Ordinary Shares - Class A.
Dr. Richard H. Scheller, Phd
Director
-
Gross Remuneration
-
Current Company
23andMe Holding Co - Ordinary Shares - Class A
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | 23andMe Holding Co - Ordinary Shares - Class A | Director | - | - |
| 2024 | 23andMe Holding Co - Ordinary Shares - Class A | Director | 349.9 K | -22.2 % |
| 2024 | Maze Therapeutics Inc. | Independent Director | 178.2 K | - |
| 2023 | BridgeBio Pharma Inc | - | 2.0 M | 111.7 % |
| 2023 | 23andMe Holding Co - Ordinary Shares - Class A | Director | 450.1 K | 147.1 % |
| 2022 | BridgeBio Pharma Inc | Chairman of Research & Development and Director | 951.8 K | -63.4 % |
| 2022 | 23andMe Holding Co - Ordinary Shares - Class A | Director | 182.2 K | - |
| 2021 | BridgeBio Pharma Inc | Chairman of Research & Development and Director | 2.6 M | 40.7 % |
| 2021 | ORIC Pharmaceuticals Inc | Independent Director | 20.3 K | -95.0 % |
| 2021 | 23andMe Holding Co - Ordinary Shares - Class A | Director | - | - |
| 2020 | BridgeBio Pharma Inc | Chairman of Research & Development and Director | 1.8 M | 54.2 % |
| 2020 | ORIC Pharmaceuticals Inc | Independent Director | 409.8 K | - |
| 2020 | 23andMe Holding Co - Ordinary Shares - Class A | Director | - | - |
| 2020 | Xenon Pharmaceuticals Inc | Independent Director | - | - |
| 2019 | BridgeBio Pharma Inc | Chairman of Research & Development and Director | 1.2 M | - |
| 2019 | ORIC Pharmaceuticals Inc | Independent Director | - | - |
| 2019 | Xenon Pharmaceuticals Inc | Independent Director | - | - |
| 2018 | Xenon Pharmaceuticals Inc | Independent Director | 109.7 K | 111.5 % |
| 2018 | BridgeBio Pharma Inc | Chairman of Research & Development and Director | - | - |
| 2017 | Xenon Pharmaceuticals Inc | Independent Director | 51.9 K | -0.9 % |
| 2016 | Xenon Pharmaceuticals Inc | Independent Director | 52.3 K | -54.6 % |
| 2015 | Xenon Pharmaceuticals Inc | Director | 115.4 K | - |
| 2014 | Xenon Pharmaceuticals Inc | Independent Director | - | - |